DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Melmed S, Cook D, Schopohl J. et al.
Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension.
Pituitary 2010; 13: 18-28
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.